These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein. Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514 [TBL] [Abstract][Full Text] [Related]
16. The effects of length and sequence of gRNA on Cas13b and Cas13d activity in vitro and in vivo. Liu Y; Jing P; Zhou Y; Zhang J; Shi J; Zhang M; Yang H; Fei J Biotechnol J; 2023 Sep; 18(9):e2300002. PubMed ID: 37148478 [TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas13 Precision Transcriptome Engineering in Cancer. Granados-Riveron JT; Aquino-Jarquin G Cancer Res; 2018 Aug; 78(15):4107-4113. PubMed ID: 30021724 [TBL] [Abstract][Full Text] [Related]
18. High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects. Tong H; Huang J; Xiao Q; He B; Dong X; Liu Y; Yang X; Han D; Wang Z; Wang X; Ying W; Zhang R; Wei Y; Xu C; Zhou Y; Li Y; Cai M; Wang Q; Xue M; Li G; Fang K; Zhang H; Yang H Nat Biotechnol; 2023 Jan; 41(1):108-119. PubMed ID: 35953673 [TBL] [Abstract][Full Text] [Related]
19. Optimized CRISPR-RfxCas13d system for RNA targeting in zebrafish embryos. Hernandez-Huertas L; Kushawah G; Diaz-Moscoso A; Tomas-Gallardo L; Moreno-Sanchez I; da Silva Pescador G; Bazzini AA; Moreno-Mateos MA STAR Protoc; 2022 Mar; 3(1):101058. PubMed ID: 35005640 [TBL] [Abstract][Full Text] [Related]
20. Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx. Sun R; Brogan D; Buchman A; Yang T; Akbari OS J Vis Exp; 2021 Feb; (168):. PubMed ID: 33616113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]